Weight-Loss Drug Cuts Heavy Drinking by 41% in New Study

Semaglutide, the active ingredient in Ozempic and Wegovy, helped people with obesity reduce heavy drinking days by 41% in a groundbreaking six-month trial.

This marks the first randomized study testing GLP-1 drugs for alcohol use disorder treatment.